AN2 Therapeutics Inc. – Filings and Transcripts

NASDAQ: ANTX
Share price (10/2/26): $5.71
Market cap (10/2/26): $215 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement

Prospectus supplement for primary offering

Shelf registration

Exempt offering of securities

Ownership Filter

Trenor Cameron C. III

Readnour Robin Shane

Readnour Robin Shane

Williams Sarah Joanne

FitzPatrick Margaret M

News Filter

Reports Second Quarter 2026 Financial Results and Recent Business and Scientific Highlights

Shareholder Vote Results

Reports Positive Enabling Data Supporting Advancement of Oral AN2-502998 to Phase 2 Study for Chronic Chagas Disease

Reports First Quarter 2026 Financial Results and Recent Business and Scientific Highlights

Other Events, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission